Nortopixantrone

Nortopixantrone

SCHEMBL29385196

CNCCNc1ccc2c3c(nn2CCNCCO)-c2cnccc2C(=O)c13

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 7/20 0.61
TOP2B Q02880 1/20 0.43
ECE1 P42892 1/20 0.38
MUS81 Q96NY9 1/20 0.38
TP53 P04637 4/20 0.36
BLM P54132 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MEN1 O00255 3/20 0.36
USP2 O75604 3/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 3/20 0.36
RECQL P46063 3/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
NSD2 O96028 2/20 0.36
CYP3A4 P08684 2/20 0.36
CSNK2A1 P68400 2/20 0.36
NPC1 O15118 1/20 0.36
SLC22A2 O15244 1/20 0.36
SLC22A1 O15245 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nortopixantrone SCHEMBL7804438 1.00 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
Nortopixantrone SCHEMBL29711469 0.99 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7810460 0.96 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7811993 0.96 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7810474 0.94 TOP2A (0.68) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804826 0.93 TOP2A (0.61) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7811757 0.92 TOP2A (0.48) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804428 0.91 TOP2A (0.68) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7804649 0.90 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53
SCHEMBL7812099 0.90 TOP2A (0.60) TOP2ATOP2BECE1MUS81TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025096952-A1 SCAFFOLDS AND SCAFFOLD HOLDERS FOR TISSUE ENGINEERING UNIVERSITY OF CONNECTICUT (US) 2025-05-08 WO disclosed
US-11607458-B2 Enrichment-triggered chemical delivery system GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2023-03-21 US disclosed
US-20220047505-A1 Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration STI PHARMA, LLC (US) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11607458-B2 Enrichment-triggered chemical delivery system HMGB1, PAICS, CCL2 TOP2A 1182/4885TOP2B 1142/4885ECE1 776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.